CAIT alleges violation of Drugs & Cosmetics Act by e-pharmacies

The legal regime, under the Drugs & Cosmetics Act, 1940, does not permit home delivery of prescription medicines for which a prescription "in original" is required

135
Online pharmacy Laptop computer Online medicine
Picture: Pixabay

Last Updated on March 22, 2021 by The Health Master

Trader’s body CAIT has written to the government alleging violation of the Drugs & Cosmetics Act by sale of e-pharmacy through e-commerce channels, saying it is adversely affecting the business of lakhs of medicine retailers and chemists.

The Confederation of All India Traders (CAIT) wrote to Commerce and Industry Minister Piyush Goyal, Health Minister Harshvardhan and Defence Minister Rajnath Singh on the issue.

Also read the draft notification about the e-pharmacy, click here

“It is important to note that sale of prescription drugs and medicines through online medium is illegal. The legal regime, under the Drugs & Cosmetics Act, 1940, does not permit home delivery of prescription medicines for which a prescription “in original” is required,” CAIT said in the letter to Goyal sent on Friday.

Medicine online
Picture: Pixabay

The traders’ body claimed that mushrooming of e-pharmacy is causing huge hardships to the retail chemists and distributors in the wake of anti-competitive practices like capital dumping and deep discounting, leading to predatory pricing.


Also read related news:

Online pharmacies urge Govt to notify e-pharmacy Rules

Online pharmacy education must become add-on to conventional system of teaching and learning: Dr…

Fake pharmacy call centre busted, 2 held

Govt should notify e-Pharmacy Draft Rules: Online Pharmacies


“As soon as the markets started reopening in October 2020, after the lockdown, e-pharmacies like PharmEasy and Medlife indulged in deep discounting on their platforms by giving a flat discount of 30 per cent,” it said in the letter to Goyal.

To capture the markets even further, an additional cashback of 20 per cent was extended to customers with free shipping. Effectively, this translated to a whopping discount of around 40 – 45 per cent with free shipping, the traders’ body added.

It alleged that e-pharmacies like Medlife and 1mg indulged in predatory pricing immediately after the lockdown by offering a 25 per cent discount on medicines and an astronomical 75 per cent discount on wellness products, a market that had begun expanding in the wake of the Covid-19 pandemic.

Responding to the allegations, PharmEasy Cofounder Dharmil Sheth said online pharmacy platforms connect the existing brick and mortar pharmacies with customers using technology. This improves accessibility, availability and ensure there is complete track and trace of medicine movement across the supply chain.

“It is time to adopt digital tools and platforms in order to bring in efficiencies and transparency in the ecosystem and enable better consumer experience,” Sheth said.

The CEO and Co-Founder of 1 mg, Prashant Tandon, said: “We enable licensed pharmacies to connect with and serve consumers seeking medicines, and all our pharmacy partners have the required licences under the Drugs & Cosmetics Act.

“Our nascent industry is just 2-3 per cent of the large and growing Indian Pharma market, and as an industry we are providing customers service and efficiency that is being appreciated”.


Also read:

Latest Notifications: COTPA (Cigarettes and Tobacco products)

Pharmacy Teachers should have good knowledge of drug development

Gujarat FDCA to host meet with USFDA for information sharing

80 plus medicines to come under under Price Regulation: NPPA

Prices of essential medicines to go up

NPPA fixes retail price of 3 formulations


He observed that all pharmacy players should consider leveraging digital technologies to enhance their business efficiency and reach, and reap the benefits of growth in line with customer expectations.

“It would help the ecosystem move forward and ensure that every small pharmacy can play a role in making National Digital Health Mission a huge success for the citizens of India. We work with thousands of pharmacies across the country and help connect them with customer demand and technology support,” Tandon said.

Email sent to Netmeds did not elicit any response till the time of filing of the story.

The Competition Commission of India earlier approved the proposed combination of Medlife and API Holdings. Medlife, a healthcare company, is primarily engaged in wholesale and distribution of drugs. API Holdings is the parent entity of API Holdings group. API Holdings is the parent of PharmEasy, as per reports.


Also read:

Procedure for obtaining Drug sale licenses (Medical store / Pharmacy)

How to change Pharmacist at Medical Store

Record keeping for Medical Store / Pharmacy

Self audit of Medical Store :105 points

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news